Published in Br J Cancer on January 01, 1994
Single amino acid (arginine) deprivation: rapid and selective death of cultured transformed and malignant cells. Br J Cancer (2000) 1.55
p53 alterations are predictive of chemoresistance and aggressiveness in ovarian carcinomas: a molecular and immunohistochemical study. Br J Cancer (1997) 1.21
Cisplatin induces a mitochondrial-ROS response that contributes to cytotoxicity depending on mitochondrial redox status and bioenergetic functions. PLoS One (2013) 1.14
The impact of S- and G2-checkpoint response on the fidelity of G1-arrest by cisplatin and its comparison to a non-cross-resistant platinum(IV) analog. Gynecol Oncol (2011) 1.13
p53-Dependent and -independent responses to cisplatin in mouse testicular teratocarcinoma cells. Proc Natl Acad Sci U S A (1998) 1.08
Inhibition of DNA Synthesis by a Platinum-Acridine Hybrid Agent Leads to Potent Cell Kill in Non-Small Cell Lung Cancer. ACS Med Chem Lett (2011) 1.06
Lobaplatin arrests cell cycle progression in human hepatocellular carcinoma cells. J Hematol Oncol (2010) 0.91
Novel irreversible small molecule inhibitors of replication protein A display single-agent activity and synergize with cisplatin. Mol Cancer Ther (2011) 0.88
Cell killing by the novel imidazoacridinone antineoplastic agent, C-1311, is inhibited at high concentrations coincident with dose-differentiated cell cycle perturbation. Br J Cancer (1996) 0.87
The effect of cisplatin pretreatment on the accumulation of MIBG by neuroblastoma cells in vitro. Br J Cancer (1997) 0.87
In vitro toxicity of different-sized ZnO nanoparticles in Caco-2 cells. Nanoscale Res Lett (2013) 0.86
Cytochemical study of role of alpha-d-mannose- and beta-d-galactose-containing glycoproteins in apoptosis. J Mol Histol (2004) 0.84
Anticancer activity and mode of action of titanocene C. Invest New Drugs (2010) 0.82
Effect of metformin on residual cells after chemotherapy in a human lung adenocarcinoma cell line. Int J Oncol (2013) 0.81
The cytotoxic action of four ammine/amine platinum(IV) dicarboxylates: a flow cytometric study. Br J Cancer (1996) 0.80
Combination therapy with cisplatin and nifedipine induces apoptosis in cisplatin-sensitive and cisplatin-resistant human glioblastoma cells. Br J Cancer (1995) 0.79
Apoptotic and non-apoptotic cell death induced by cis and trans analogues of a novel ammine(cyclohexylamine)dihydroxodichloroplatinum(IV) complex. Br J Cancer (1996) 0.79
SUMOylation is developmentally regulated and required for cell pairing during conjugation in Tetrahymena thermophila. Eukaryot Cell (2014) 0.78
Drug-induced death of leukaemic cells after G2/M arrest: higher order DNA fragmentation as an indicator of mechanism. Br J Cancer (1998) 0.78
Platinum-(IV)-derivative satraplatin induced G2/M cell cycle perturbation via p53-p21(waf1/cip1)-independent pathway in human colorectal cancer cells. Acta Pharmacol Sin (2011) 0.78
Gene-specific repair of Pt/DNA lesions and induction of apoptosis by the oral platinum drug JM216 in three human ovarian carcinoma cell lines sensitive and resistant to cisplatin. Br J Cancer (1999) 0.78
Induction of apoptosis and non-apoptosis in human breast cancer cell line (MCF-7) by cisplatin and caffeine. Iran Biomed J (2011) 0.77
In Silico Oncology: Quantification of the In Vivo Antitumor Efficacy of Cisplatin-Based Doublet Therapy in Non-Small Cell Lung Cancer (NSCLC) through a Multiscale Mechanistic Model. PLoS Comput Biol (2016) 0.75
Cell death: the significance of apoptosis. Int Rev Cytol (1980) 24.88
Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature (1980) 17.69
A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods (1991) 16.64
Features of apoptotic cells measured by flow cytometry. Cytometry (1992) 6.45
Apoptosis: mechanisms and roles in pathology. Int Rev Exp Pathol (1991) 4.89
Key morphological features of apoptosis may occur in the absence of internucleosomal DNA fragmentation. Biochem J (1992) 3.23
Apoptosis induced by anticancer drugs. Cancer Metastasis Rev (1992) 3.07
The formation, isolation and characterization of DNA adducts produced by anticancer platinum complexes. Pharmacol Ther (1987) 2.96
Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia. Biochem Pharmacol (1990) 2.60
Topoisomerase II-reactive chemotherapeutic drugs induce apoptosis in thymocytes. Cancer Res (1991) 2.46
Analysis and discrimination of necrosis and apoptosis (programmed cell death) by multiparameter flow cytometry. Biochim Biophys Acta (1992) 2.33
Comparative evaluation of several DNA binding dyes in the detection of apoptosis-associated chromatin degradation by flow cytometry. Cytometry (1992) 2.30
Apoptosis (the 1992 Frank Rose Memorial Lecture). Br J Cancer (1993) 2.20
The mechanism of action of antitumor platinum compounds. Prog Nucleic Acid Res Mol Biol (1979) 2.19
Analysis of events associated with cell cycle arrest at G2 phase and cell death induced by cisplatin. J Natl Cancer Inst (1990) 2.06
Drug-target interactions: only the first step in the commitment to a programmed cell death? Br J Cancer (1991) 2.01
Regulation of apoptosis in interleukin-3-dependent hemopoietic cells by interleukin-3 and calcium ionophores. EMBO J (1990) 1.94
Evaluation of glucocorticoid-induced DNA fragmentation in mouse thymocytes by flow cytometry. Cell Prolif (1991) 1.60
Apoptosis in interleukin-3-dependent haemopoietic cells. Quantification by two flow cytometric methods. J Immunol Methods (1992) 1.53
Apoptosis in C3H/10T1/2 mouse embryonic cells: evidence for internucleosomal DNA modification in the absence of double-strand cleavage. Proc Natl Acad Sci U S A (1993) 1.32
Influence of cis-diamminedichloroplatinum(II) on DNA synthesis and cell cycle progression in excision repair proficient and deficient Chinese hamster ovary cells. Cancer Res (1988) 1.31
A flow-cytometric method for the separation and quantitation of normal and apoptotic thymocytes. Anal Biochem (1992) 1.25
Interstrand cross-links and sequence specificity in the reaction of cis-dichloro(ethylenediamine)platinum(II) with DNA. Biochemistry (1985) 1.19
Defective removal of DNA cross-links in a repair-deficient mutant of Chinese hamster cells. Cancer Res (1982) 1.05
BrdU-Hoechst flow cytometry: a unique tool for quantitative cell cycle analysis. Exp Cell Res (1988) 1.05
Quantitative estimation of cisplatin-induced DNA interstrand cross-links and their repair in mammalian cells: relationship to toxicity. Pharmacol Ther (1987) 1.02
Excision repair of cis-diamminedichloroplatinum(II)-induced damage to DNA of Chinese hamster cells. Cancer Res (1979) 0.99
Increased membrane permeability of apoptotic thymocytes: a flow cytometric study. Cytometry (1993) 0.96
Analysis of glucocorticoid actions on rat thymocyte deoxyribonucleic acid by fluorescence-activated flow cytometry. Endocrinology (1988) 0.95
Apoptosis of rat thymocytes triggered by prednisolone, camptothecin, or teniposide is selective to G0 cells and is prevented by inhibitors of proteases. Oncol Res (1992) 0.94
Changes in nuclear chromatin related to apoptosis or necrosis induced by the DNA topoisomerase II inhibitor fostriecin in MOLT-4 and HL-60 cells are revealed by altered DNA sensitivity to denaturation. Exp Cell Res (1992) 0.87
Cell cycle analysis of asynchronous cell populations by flow cytometry using bromodeoxyuridine label and Hoechst-propidium iodide stain. Cytometry (1992) 0.86
Flow cytometric analysis of the kinetic effects of cisplatin on lung cancer cells. Cytometry (1989) 0.86
Protein kinase-C involvement in thymocyte apoptosis induced by hydrocortisone. Cell Immunol (1990) 0.85
BrdUrd/DNA flow cytometry analysis demonstrates cis-diamminedichloroplatinum (II)-induced multiple cell-cycle modifications on human lung carcinoma cells. Cytometry (1992) 0.84
cis-Pt(NH3)2Cl2 and trans-Pt(NH3)2Cl2 inhibit DNA synthesis in cultured L1210 leukemia cells. Biochem Biophys Res Commun (1983) 0.83
Quantitative determination of the induction of apoptosis in a murine B cell line using flow cytometric bivariate cell cycle analysis. Cell Immunol (1992) 0.83
Synergistic cell inactivation by cis-dichlorodiammineplatinum in combination with 1-propargyl-5-chloropyrimidin-2-one. Br J Cancer (1987) 0.83
In vitro cytokinetic response of human colon cancer cells to cis-dichlorodiammineplatinum(II). Cancer Res (1979) 0.82
Effects of cis-platinum(II) diamminedichloride on survival and the rate of DNA synthesis in synchronously growing HeLa cells in the absence and presence of caffeine. Chem Biol Interact (1978) 0.78
Tumour volume response, initial cell kill and cellular repopulation in B16 melanoma treated with cyclophosphamide and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea. Br J Cancer (1977) 2.31
Repopulation of gamma-irradiated Lewis lung carcinoma by malignant cells and host macrophage progenitors. Br J Cancer (1978) 1.77
Electrogenesis in mouse neuroblastoma cells in vitro. J Cell Physiol (1971) 1.66
Cellular radiosensitivity and DNA damage in primary human fibroblasts. Int J Radiat Oncol Biol Phys (1994) 1.55
The relationship between cellular radiation sensitivity and tissue response may provide the basis for individualising radiotherapy schedules. Radiother Oncol (1994) 1.54
Cell survival in B16 melanoma after treatment with combinations of cytotoxic agents: lack of potentiation. Br J Cancer (1977) 1.51
Electrophysiologic study of cultured neurons dissociated from spinal cords and dorsal root ganglia of fetal mice. Dev Biol (1973) 1.42
Cell yield and cell survival following chemotherapy of the B16 melanoma. Br J Cancer (1978) 1.30
Enhanced cell killing in lewis lung carcinoma and a human pancreatic-carcinoma xenograft by the combination of cytotoxic drugs and misonidazole. Br J Cancer (1981) 1.23
Electrotonic structure and specific membrane properties of mouse dorsal root ganglion neurons. J Neurophysiol (1981) 1.16
DBS and diathermy interaction induces severe CNS damage. Neurology (2001) 1.12
The dose-rate effect in human tumour cells. Radiother Oncol (1987) 1.10
Dose-rate effects and the repair of radiation damage. Radiother Oncol (1986) 1.09
Influence of anaesthetics on tumour-cell kill and repopulation in B16 melanoma treated with melphalan. Br J Cancer (1978) 1.09
Morphology of dissociated hippocampal cultures from fetal mice. Brain Res (1979) 1.07
Effect of gamma radiation at high- and low-dose rate on a novel in vivo mutation assay in mouse intestine. Mutagenesis (1989) 1.07
Normal tissue radiosensitivity--how important is it? Clin Oncol (R Coll Radiol) (1996) 1.06
The radiobiology of human cells and tissues. In vitro radiosensitivity. The picture has changed in the 1980s. Int J Radiat Biol (1989) 1.05
The relationship of DNA double-strand break induction to radiosensitivity in human tumour cell lines. Int J Radiat Biol (1990) 1.04
Improving cancer outcomes through radiotherapy. Lack of UK radiotherapy resources prejudices cancer outcomes. BMJ (2000) 1.04
Orthotopic liver homotransplantation: coagulation and hematologic changes in the pig. Arch Surg (1968) 1.01
The 5Rs of radiobiology. Int J Radiat Biol (1989) 1.00
A panel of human lung carcinoma lines: establishment, properties and common characteristics. Br J Cancer (1987) 0.97
Influence of in vitro assay conditions on the assessment of radiobiological parameters of the MT tumour. Br J Radiol (1980) 0.97
Responses of neuroblastoma cells to iontophoretically applied acetylcholine. J Cell Physiol (1971) 0.97
The technique of orthotopic liver homotransplantation in the pig. J Surg Res (1968) 0.96
Radiosensitivity, recovery and dose-rate effect in three human glioma cell lines. Radiother Oncol (1990) 0.95
Wiring in the treatment of aortic aneurysms. Br J Surg (1968) 0.95
Prediction of normal-tissue tolerance to radiotherapy from in-vitro cellular radiation sensitivity. Lancet (1992) 0.93
Chromatin structure and cellular radiosensitivity: a comparison of two human tumour cell lines. Int J Radiat Biol (1996) 0.92
Prognosis after portocaval anastomosis: a 15-year follow-up. Br J Surg (1975) 0.90
Acetylcholine responses in L cells. Science (1972) 0.90
Why are some human tumours more radiosensitive than others? Radiother Oncol (1989) 0.89
Pulsed Doppler angiography in lower limb arterial ischemia. Surgery (1979) 0.89
Glutathione determination by the Tietze enzymatic recycling assay and its relationship to cellular radiation response. Br J Cancer (1995) 0.89
Regulation of acetylcholine receptor levels by a cholinergic agonist in mouse muscle cell cultures. Proc Natl Acad Sci U S A (1978) 0.89
Primary aortoduodenal fistula following radiotherapy. Surg Gynecol Obstet (1983) 0.89
Pharmacokinetics of G3139, a phosphorothioate oligodeoxynucleotide antisense to bcl-2, after intravenous administration or continuous subcutaneous infusion to mice. J Pharmacol Exp Ther (1997) 0.89
Comparison of DNA repair protein expression and activities between human fibroblast cell lines with different radiosensitivities. Int J Cancer (2000) 0.88
The effect of cytotoxic drugs with or without misonidazole on leucopenia in three strains of mice. Int J Radiat Oncol Biol Phys (1982) 0.88
Action of actinomycin D, bleomycin and x rays on HeLa cells. Br J Radiol (1973) 0.87
Hypothermic low flow liver perfusion as a means of porcine hepatic storage for six hours. Br J Surg (1968) 0.87
Induction of apoptosis by a novel copper-based anticancer compound, casiopeina II, in L1210 murine leukaemia and CH1 human ovarian carcinoma cells. Toxicol In Vitro (2000) 0.86
The role of platinum uptake and glutathione levels in L1210 cells sensitive and resistant to cisplatin, tetraplatin or carboplatin. Neoplasma (1992) 0.86
The relative cellular radiosensitivity of 30 human in vitro cell lines of different histological type to high LET 62.5 MeV (p-->Be+) fast neutrons and 4 MeV photons. Radiother Oncol (1994) 0.85
A case of Alzheimer's disease and hippocampal sclerosis with normal cholinergic activity in basal forebrain, neocortex, and hippocampus. Neurology (1989) 0.85
Recognition and prevention of intraoperative warm-ischaemia in liver transplantation. Br Med J (1968) 0.85
Heterogeneity of radiosensitivity in a human glioma cell line. Int J Radiat Oncol Biol Phys (1992) 0.85
Low dose-rate fibroblast radiosensitivity and the prediction of patient response to radiotherapy. Int J Radiat Biol (1996) 0.85
A transportable apparatus for liver preservation. Eur Surg Res (1970) 0.85
Transmission on an active electrical response between fibroblasts (L cells) in cell culture. J Gen Physiol (1973) 0.84
Clonal variation in the sensitivity of B16 melanoma to m-AMSA. Br J Cancer (1982) 0.84
Molecular determinants of radiosensitivity in mammalian cells. Int J Radiat Biol (1994) 0.83
Novel trans platinum complexes: comparative in vitro and in vivo activity against platinum-sensitive and resistant murine tumours. Anticancer Res (1996) 0.83
Dose-rate effect for DNA damage induced by ionizing radiation in human tumor cells. Radiat Res (1994) 0.83
DNA damage and prediction of radiation response in lymphocytes and epidermal skin human cells. Int J Cancer (1998) 0.83
Identification of a subpopulation of MeCCNU resistant cells in previously untreated Lewis lung tumours. Br J Cancer (1984) 0.83
Transaxillary sympathectomy--is a one-stage bilateral procedure safe? Br J Surg (1982) 0.82
Enhancement of cytotoxic drugs by misonidazole (MISO) in Lewis lung tumors of different sizes, and mouse bone marrow. Int J Radiat Oncol Biol Phys (1982) 0.82
Electrical excitability and chemosensitivity of mouse neuroblastoma X mouse or human fibroblast hybrids. Exp Eye Res (1973) 0.81
Electrical activity in dissociated cell cultures from fetal mouse cerebellum. Brain Res (1973) 0.81
Orthotopic liver homotransplantation: an experimental study in the unmodified pig. S Afr Med J (1968) 0.81
Prednisone-neostigmine interactions at cholinergic junctions. Muscle Nerve (1980) 0.81
Increased collagen production in fibroblasts cultured from irradiated skin and effect of TGF beta(1)- clinical study. Br J Cancer (2000) 0.81
The inherent cellular sensitivity to 62.5 MeV(p----Be+) neutrons of human cells differing in photon sensitivity. Int J Radiat Biol (1992) 0.81
The radiation dose-rate effect in two human neuroblastoma cell lines. Br J Cancer (1990) 0.80
Spinal cord infarction during use of zolmitriptan: a case report. Headache (2000) 0.80
Synaptogenesis in cell cultures of neurones and myotubes from chickens with muscular dystrophy. J Neurol Neurosurg Psychiatry (1973) 0.80
Continuous irradiation of the Lewis lung carcinoma in vivo at clinically-used "ultra" low-dose-rates. Int J Radiat Oncol Biol Phys (1983) 0.80
The acute in vitro and in vivo radiosensitivity of human lung tumour lines. Radiother Oncol (1986) 0.80
The cytotoxic action of four ammine/amine platinum(IV) dicarboxylates: a flow cytometric study. Br J Cancer (1996) 0.80
The radiosensitivity of human neuroblastoma: a cellular and molecular study. Int J Radiat Biol (1989) 0.79
Host cell reactivation of gamma-irradiated adenovirus 5 in human cell lines of varying radiosensitivity. Br J Cancer (1992) 0.79
Development of MeCCNU-resistance in clonally derived lines of Lewis lung carcinoma. Eur J Cancer Clin Oncol (1987) 0.79
Glutathione manipulation and the radiosensitivity of human tumour and fibroblast cell lines. Int J Radiat Biol (1995) 0.79
Emergence of nitrosourea resistant sublines of Lewis lung tumour following MeCCNU treatment in vivo. Br J Cancer (1986) 0.79
Electrophysiology of dissociated hippocampal cultures from fetal mice. Brain Res (1979) 0.78
The differential induction of collateral resistance to 62.5 MeV (p-->Be+) neutrons and 4 MeV photons by exposure to cis-platinum. Int J Radiat Oncol Biol Phys (1993) 0.78
Studies on the radiobiology of a rat sarcoma treated in situ and assayed in vitro. Eur J Cancer (1973) 0.78
Split-dose and low dose-rate recovery in four experimental tumour systems. Int J Radiat Biol Relat Stud Phys Chem Med (1987) 0.78
Chemosensitivity of mouse neuroblastoma cells in vitro. J Neurobiol (1973) 0.78
Differences in the level of DNA double-strand breaks in human tumour cell lines following low dose-rate irradiation. Eur J Cancer (1992) 0.78
Radiosensitivity of the B16 melanoma is not significantly influenced by melanin content. Int J Radiat Biol Relat Stud Phys Chem Med (1986) 0.78
Identification of human in vitro cell lines with greater intrinsic cellular radiosensitivity to 62.5 MeV (p-->Be+) neutrons than 4 MeV photons. Int J Radiat Oncol Biol Phys (1994) 0.78
Postjunctional changes induced by partial interruption of axoplasmic flow in motor nerves. Exp Neurol (1973) 0.78
Retrograde cell degeneration in adult cat after hemidecortication. J Comp Neurol (1965) 0.77
Temporal interactions in the Lewis lung tumour between cytotoxic drugs and acute or fractionated radiotherapy. Radiother Oncol (1986) 0.77
Hypothermic perfusion as a method of shor-term porcine liver storage. Br J Surg (1968) 0.77
Soluble and membrane-bound forms of brain acetylcholinesterase in Alzheimer's disease. Neurobiol Aging (1993) 0.77
Morphological and functional correlates of synchronous beating between embryonic heart cell aggregates and layers. Exp Cell Res (1978) 0.77
Response to continuous irradiation (CI) in relation to the initial slope of the cell survival curve for tumours and bone marrow. Br J Cancer Suppl (1984) 0.77
The influence of hypoxia on the relative sensitivity of human tumor cells to 62.5 MeV (p-->Be) fast neutrons and 4 MeV photons. Radiat Res (2000) 0.76
Cellular sensitivity and low dose-rate recovery in Fanconi anaemia fibroblasts. Br J Radiol (1994) 0.76
Decrease in membrane-bound G4 form of acetylcholinesterase in postmortem Alzheimer brain. Prog Clin Biol Res (1989) 0.76
Comparison of growth delay and cell survival as end-points of tumour response following treatment with combinations of cytotoxic agents. Br J Cancer Suppl (1980) 0.75
Experimental appraisal of factors involved in provision of donor livers. Br Med J (1969) 0.75
Thrombocytopenia with absent radii (TAR) syndrome: a new increased cellular radiosensitivity syndrome. Clin Oncol (R Coll Radiol) (1995) 0.75
Comparison between normal tissue reactions and local tumour control in head and neck cancer patients treated by definitive radiotherapy: regarding IJROBP 35:455-462; 1996. Int J Radiat Oncol Biol Phys (1997) 0.75
Electrical excitability and chemosensitivity of mouse neuroblastoma X mouse or human fibroblast hybrids. Exp Cell Res (1973) 0.75